Director Ronald T Hundzinski bought 5,000 shares of INFU at $6.09; cluster pattern with 2 other insiders buying within 14 days
Director Hundzinski initiated a position of 5,000 shares at $6.09 on 2025-05-19, spending $30,450.00. The transaction occurs within a cluster pattern where 2 other insiders also purchased within the past 14 days, suggesting aligned interest in the stock at current levels. INFU is trading at $6.10, near the transaction price, after a +24.2% move over the past 30 days but remains -28.7% over 90 days and -35.9% from its 52-week high of $9.51. The company reported $34.7M in latest quarterly revenue with annual growth of +7.2%, though net income was negative at $-267.0K, indicating operational challenges despite top-line growth.
Director Ronald T Hundzinski buys 5,000 THRM shares at $26.67; stock -49.4% from 52-week high amid flat revenue growth
Hundzinski purchased 5,000 shares at $26.67 on 2025-05-08, increasing his holdings by +38.4% to 18,006 shares. The transaction occurs at a price 49.4% below the 52-week high of $55.18, though the stock has recovered 19.8% over the prior 30 days from a recent low. Gentherm's fundamentals show revenue of $353.9M in the latest quarter with flat annual revenue growth of -0.9% and a net loss of $-128.0K, presenting a context where the director's purchase arrives at depressed valuation levels but amid weak financial momentum. This open-market buy by a director during a price recovery phase, despite stagnant topline performance, warrants tracking to determine whether it reflects management confidence in a turnaround or reflects valuation-driven opportunism at a temporary low.
